ALTERNATING NON-CROSS-RESISTANT COMBINATION CHEMOTHERAPY OR MOPP IN STAGE-IV HODGKINS-DISEASE - A REPORT OF 8-YEAR RESULTS

被引：335
作者：
BONADONNA, G
VALAGUSSA, P
SANTORO, A
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 1986年 / 104卷 / 06期
关键词：
D O I：
10.7326/0003-4819-104-6-739
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：739 / 746
页数：8
相关论文
共 37 条
[1]   BCVPP CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE - EVIDENCE FOR GREATER DURATION OF COMPLETE REMISSION, GREATER SURVIVAL, AND LESS TOXICITY THAN WITH A MOPP REGIMEN [J].
BAKEMEIER, RF ;
ANDERSON, JR ;
COSTELLO, W ;
ROSNER, G ;
HORTON, J ;
GLICK, JH ;
HINES, JD ;
BERARD, CW ;
DEVITA, VT .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) :447-456
[2]  
BONADONNA G, 1985, CANCER SURV, V4, P439
[3]   10-YEAR EXPERIENCE WITH CMF-BASED ADJUVANT CHEMOTHERAPY IN RESECTABLE BREAST-CANCER [J].
BONADONNA, G ;
VALAGUSSA, P ;
ROSSI, A ;
TANCINI, G ;
BRAMBILLA, C ;
ZAMBETTI, M ;
VERONESI, U .
BREAST CANCER RESEARCH AND TREATMENT, 1985, 5 (02) :95-115
[4]  
BONADONNA G, 1982, CANCER RES, V42, P4309
[5]   EVOLUTION IN THE TREATMENT STRATEGY OF HODGKINS-DISEASE [J].
BONADONNA, G ;
SANTORO, A .
ADVANCES IN CANCER RESEARCH, 1982, 36 :257-293
[6]  
BONADONNA G, 1985, SEMIN ONCOL, V12, P23
[7]  
BONADONNA G, 1975, CANCER, V36, P252, DOI 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO
[8]  
2-7
[9]   ABVD CHEMOTHERAPY IN THE TREATMENT OF HODGKINS-DISEASE [J].
BONADONNA, G ;
SANTORO, A .
CANCER TREATMENT REVIEWS, 1982, 9 (01) :21-35
[10]  
CARBONE PP, 1971, CANCER RES, V31, P1860
1234